Starpharma Holdings Ltd (SPHRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,860 | -13,430 | 0 | 0 | -8,830 |
| Depreciation Amortization | 1,020 | 1,000 | 0 | 0 | 1,510 |
| Other Working Capital | 2,770 | 2,090 | 0 | 0 | -350 |
| Other Operating Activity | 680 | 1,330 | -10,060 | -10,080 | 1,270 |
| Operating Cash Flow | $-11,390 | $-9,010 | $-10,060 | $-10,080 | $-6,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -540 | -230 | -160 | -130 | -130 |
| Investing Cash Flow | $-540 | $-230 | $-160 | $-130 | $-130 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 17,140 | 180 | 850 | 34,760 | 3,470 |
| Financing Cash Flow | $17,140 | $180 | $850 | $34,760 | $3,470 |
| Exchange Rate Effect | 510 | 40 | 150 | 130 | -810 |
| Beginning Cash Position | 20,110 | 31,070 | 43,980 | 19,530 | 22,600 |
| End Cash Position | 25,820 | 22,060 | 34,760 | 44,210 | 18,710 |
| Net Cash Flow | $5,710 | $-9,010 | $-9,210 | $24,670 | $-3,890 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,390 | -9,010 | -10,060 | -10,080 | -6,400 |
| Free Cash Flow | -11,390 | -9,010 | -10,060 | -10,080 | -6,400 |